People · Operator
Named in public records as an officer, director or promoter · active 2012–2021 · Other Energy, Other Technology, Other, Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BrightSource Energy Inc | — | Other Energy | Series D+ | $505.8M | $110.8M | 2012 |
| Lighting Science Group Corp | — | Other Technology | Series C | $248.7M | $565.7M | 2013 |
| ONX, Inc. | — | Other | Series D+ | $167.3M | $2.5B | 2021 |
| Revivermx, Inc. | — | Other Technology | Series B | $104.3M | $231.8M | 2017 |
| Alveo Technologies Inc. | — | Biotechnology | Series C | $63.6M | $503.0M | 2021 |
| Slate Technologies, Inc. | — | Software / Tech | Series B | $20.2M | $490.6M | 2021 |
| Bossa Nova Robotics Holding Corp. | — | Other Technology | Series A | $19.8M | $297.6M | 2015 |
| Skully, Inc. | — | Other Technology | Series A | $10.5M | $249.7M | 2015 |
| Riverwood Solutions, Inc. | — | Other | Seed | $3.2M | $37.2M | 2015 |
Nicholas Brathwaite at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas Brathwaite on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Marks | 2 | 20 |
| Ashish Bhardwaj | 2 | 2 |
| Isaac Blech | 1 | 14 |
| John Thompson | 1 | 13 |
| Jonathan Rosenbaum | 1 | 9 |
| Richard Davis | 1 | 8 |
| Lokesh Sikaria | 1 | 6 |
| Michael Jackson | 1 | 6 |
| Thomas Smach | 1 | 4 |
| Victor Westerlind | 1 | 4 |
| David Kruse | 1 | 3 |
| David Nielsen | 1 | 3 |
| Edward Bednarcik | 1 | 3 |
| Robert Wood | 1 | 3 |
| Andrew Cooper | 1 | 3 |
| Thomas J. Smach | 1 | 3 |
| John Bryson | 1 | 3 |
| Craig Cogut | 1 | 3 |
| Lawrence Blatt | 1 | 3 |
| Nicholas Braithwaite | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.